on June 23, 2005
Published online before print June 23, 2005, doi: 10.1161/01.ATV.0000174806.76629.7b
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 13, 2005
Accepted on June 7, 2005
Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia
Carla Y. Vossen ;
From the Department of Clinical Epidemiology (C.Y.V., F.R.R.), Leiden University Medical Center, Leiden, The Netherlands; the Department of Haematology (I.D.W.), Glasgow Royal Infirmary, Glasgow, UK; the Department for Coagulation Disorders (P.S.), University Hospital, Malmö, Sweden; the Department of Haematology J.C.S., J.F.), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; the Department of Internal Medicine (I.S.), University Hospital, Frankfurt/Main, Germany; the Department of Haematology (F.E.P., M.M.), Royal Hallamshire Hospital, Sheffield, UK; the Department of Angiology and Blood Coagulation (G.P.), University Hospital S. Orsola, Bologna, Italy; the Department of Haematology and Haemostaseology (I.P.), University Hospital Vienna, Vienna, Austria; the Department of Haematology (F.J.M.v.d.M., F.R.R.), Leiden University Medical Center, Leiden, The Netherlands; and the Department of Biological Haematology (J.C.), Hôtel-Dieu Hospital, Paris, France.
* To whom correspondence should be addressed. E-mail: F.R.Rosendaal{at}lumc.nl.
Objective--Few comprehensive data are available on the recurrence rate of venous thrombosis in carriers of thrombophilic defects from thrombophilic families. We prospectively determined the recurrence rate after a first venous thrombotic event in patients with familial thrombophilia attributable to factor V Leiden or deficiencies of protein C, S, or antithrombin.
Methods and Results--Data were gathered during follow-up on the occurrence of risk situations, anticoagulation treatment, and events (eg, venous thrombosis, hemorrhage). Over a mean follow-up period of 5.6 years, 44 of the 180 patients with familial thrombophilia who did not use long-term anticoagulation experienced a recurrent venous thromboembolic event (5.0%/year; 95% CI 3.6 to 6.7) compared with 7 of the 124 patients on long-term anticoagulation (1.1%/year; 95% CI 0.4 to 2.2). Spontaneous events occurred less often in patients on long-term anticoagulation (57%) than in patients without long-term anticoagulation (75%). The highest recurrence rate was found among men with a deficiency in natural anticoagulants or multiple defects and women with antithrombin deficiency. Although long-term anticoagulation treatment decreased the incidence of recurrent events by 80%, it also resulted in a risk of major hemorrhage of 0.8% per year.
Conclusions--Extra care after a first event is required for men with a deficiency in natural anticoagulants or multiple defects and women with antithrombin deficiency.
Key words: familial thrombophilia • incidence • prospective follow-up • recurrence • venous thrombosis
This article has been cited by other articles:
 |
|
 |
|
  C. Laczkovics, H. Grafenhofer, A. Kaider, P. Quehenberger, R. Simanek, C. Mannhalter, K. Lechner, and I. Pabinger Risk of recurrence after a first venous thromboembolic event in young women Haematologica, September 1, 2007; 92(9): 1201 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Heit Thrombophilia: Common Questions on Laboratory Assessment and Management Hematology, January 1, 2007; 2007(1): 127 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cushman Inherited Risk Factors for Venous Thrombosis Hematology, January 1, 2005; 2005(1): 452 - 457. [Abstract] [Full Text] [PDF]
|
|